Brazil Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion), By Product (Pharmaceuticals, Biologics), By Type Of Vaccines, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030
Brazil Animal Health Market Growth & Trends The Brazil animal health market size is expected to reach USD 4.29 billion by 2030, registering a CAGR of 8.60% from 2025 to 2030, according to a new ... もっと見る
SummaryBrazil Animal Health Market Growth & TrendsThe Brazil animal health market size is expected to reach USD 4.29 billion by 2030, registering a CAGR of 8.60% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary drivers of market growth include the rising prevalence of diseases in animals, rising pet ownership, increasing number of surgical procedures, and increasing animal health expenditure. Furthermore, Brazil is one of the world's largest producers of beef, poultry, and pork. The increasing global demand for high-quality protein drives the need for better animal health solutions to ensure productivity and export competitiveness. For instance, according to the news published in October 2024, Brazil exported 286,750 tons of beef by September 2024, marking record sales in the history. The country supplies beef to more than 150 countries in the world. Due to this rising demand for protein in large mass of people the revenue in the animal health sector is expected to surge in the coming years. In addition, pet insurance acceptability is increasing due to several causes, including pet humanization, expanding pet population, increased initiatives by major corporations, and rising veterinary care costs. The AVMA reports that pet owners are increasingly using pet insurance to help them pay for their pets' medical expenses. Also, to prevent the growth of stray animals, control over reproduction of animals is needed, which further increases the overall number of veterinary visits, driving the demand for veterinary pharmaceuticals. The use of sedatives in spaying dogs is an essential part of the veterinary procedure, ensuring the safety and comfort of the animal. For instance, according to the data mentioned by Virbac, 30 to 40% of dogs are neutered in Latin America especially with the help of surgeries. The company had also planned initiatives in 2023 to provide non-surgical solutions for fertility management in dogs in Brazil. Such activities are attributed to expand the adoption of veterinary medicines in Brazil, propelling market growth. Moreover, Brazilian pet population growth is fueling the market growth. Over the past few years, the number of pets has increased drastically as more and more households have decided to adopt a pet in an effort to improve their quality of life. According to the data reported in World Population Review, Brazil is home to over 35 million domestic dogs, which makes it the second largest population of dogs in the world. This increasing population of pets in the country drives the necessity for treating a variety of illnesses, such as arthritis in dogs and cats which further accelerates the growth of animal health market. Brazil Animal Health Market Report Highlights • Based on product, pharmaceuticals held the dominant revenue share in 2024. Increasing demand for potent medicines due to the rising prevalence of several veterinary diseases fuel the market growth. • Based on disease, the cattle diseases dominated the market in 2024. The prevalence of diseases such as Foot-and-Mouth Disease (FMD), Bovine Respiratory Disease Complex, and Bovine Viral Diarrhea has necessitated substantial investments in vaccines and biosecurity measures leading to their majority market share. • Based on animal type, the production animals dominated the market in 2024 due to the increasing trend of protein-based food, poultry market has significantly grown in the recent years. • Based on route of administration, oral segment dominated the market in 2024. Oral route of administration provides easy ingestion and show effective results for various therapeutic conditions. • Based on distribution channel, the hospital/ clinic pharmacy segment dominated the animal health market in 2024. This can be attributed to the growing patient footfall in these hospitals to treat medical conditions in animals. Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.1.1. Scope 1.1.2. Estimates And Forecast Timeline 1.2. Market Definitions 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. GVR’s Internal Database 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis 1.6.2. Global Market: CAGR Calculation 1.7. Research Scope and Assumptions 1.7.1. List of Secondary Sources 1.7.2. List of Primary Sources 1.7.3. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights Chapter 3. BRAZIL Animal Health Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Drivers Analysis 3.2.1.1. Rising demand for animal protein 3.2.1.2. Supportive initiatives by Government 3.2.2. Market Restraints Analysis 3.2.2.1. Limited access to veterinary care 3.2.3. Market Opportunity Analysis 3.2.4. Market Challenges Analysis 3.3. BRAZIL Animal Health Market Analysis Tools 3.3.1. Porter’s Analysis 3.3.1.1. Bargaining power of the suppliers 3.3.1.2. Bargaining power of the buyers 3.3.1.3. Threats of substitution 3.3.1.4. Threats from new entrants 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Economic and Social Landscape 3.3.2.3. Technological landscape 3.3.2.4. Environmental Landscape 3.3.2.5. Legal landscape 3.4. Covid-19 Analysis 3.5. Estimated Pet Population by key countries Chapter 4. Brazil Animal Health Market: Animal Estimates & Trend Analysis 4.1. Segment Dashboard 4.2. Brazil Animal Health Market Movement Analysis 4.3. Brazil Animal Health Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million) 4.3.1. Production Animals 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.1.2. Poultry 4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.1.3. Swine 4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.1.4. Cattles 4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.1.5. Sheep & Goats 4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.1.6. Fish 4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.2. Companion Animals 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.2.2. Dogs 4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.2.3. Cats 4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.2.4. Horses 4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 4.3.2.5. Others 4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) Chapter 5. Brazil Animal Health Market: Product Estimates & Trend Analysis 5.1. Segment Dashboard 5.2. Brazil Animal Health Market Movement Analysis 5.3. Brazil Animal Health Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million) 5.3.1. Biologics 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2. Vaccines 5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.2. Attenuated Live Vaccines 5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.3. Inactivated Vaccines 5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.4. Subunit Vaccines 5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.5. DNA Vaccines 5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.5.2. Recombinant Vaccines 5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.5.4. Autogenous Vaccines 5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.1.2.5.6. Other Biologics 5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2. Pharmaceuticals 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2.2. Parasiticides 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2.3. Anti-infectives 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2.4. Anti-inflammatory 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2.5. Analgesics 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.2.6. Other Pharmaceuticals 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) 5.3.3. Medicinal Feed Additives 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) Chapter 6. Brazil Animal Health Market: Type of Vaccine Estimates & Trend Analysis 6.1. Segment Dashboard 6.2. Brazil Animal Health Market Movement Analysis 6.3. Brazil Animal Health Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million) 6.3.1. Cattle Vaccine 6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 6.3.2. Porcine Vaccine 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 6.3.3. Poultry Vaccine 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 6.3.4. Aquaculture Vaccine 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 6.3.5. Other Vaccines 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) Chapter 7. Brazil Animal Health Market: Disease Estimates & Trend Analysis 7.1. Segment Dashboard 7.2. Brazil Animal Health Market Movement Analysis 7.3. Brazil Animal Health Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million) 7.3.1. Cattle Disease 7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 7.3.2. Porcine Disease 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 7.3.3. Poultry Disease 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 7.3.4. Aquaculture Disease 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 7.3.5. Other Disease 7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) Chapter 8. Brazil Animal Health Market: Route of Administration Estimates & Trend Analysis 8.1. Segment Dashboard 8.2. Brazil Animal Health Market Movement Analysis 8.3. Brazil Animal Health Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million) 8.3.1. Oral 8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.2. Injectable 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.2.2. Subcutaneous 8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.2.3. Intramuscular 8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.2.4. Intravenous 8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.3. Topical 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 8.3.4. Other 8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) Chapter 9. Brazil Animal Health Market: Distribution Channel Estimates & Trend Analysis 9.1. Segment Dashboard 9.2. Brazil Animal Health Market Movement Analysis 9.3. Brazil Animal Health Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million) 9.3.1. Retail 9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 9.3.2. E-Commerce 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) 9.3.3. Hospital/ Clinic Pharmacy 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) Chapter 10. Competitive Landscape 10.1. Market Participant Categorization 10.2. Company Market Position Analysis/ Heat Map Analysis 10.3. Strategy Mapping 10.3.1. Mergers & Acquisitions 10.3.2. Partnerships & Collaborations 10.3.3. Others 10.4. Company Profiles 10.4.1. Zoetis Inc. 10.4.1.1. Participant’s Overview 10.4.1.2. Financial Performance 10.4.1.3. Product Benchmarking 10.4.1.4. Strategic Initiatives 10.4.2. Ceva Santé Animale 10.4.2.1. Participant’s Overview 10.4.2.2. Financial Performance 10.4.2.3. Product Benchmarking 10.4.2.4. Strategic Initiatives 10.4.3. Merck & Co., Inc. 10.4.3.1. Participant’s Overview 10.4.3.2. Financial Performance 10.4.3.3. Product Benchmarking 10.4.3.4. Strategic Initiatives 10.4.4. Vetoquinol S.A. 10.4.4.1. Participant’s Overview 10.4.4.2. Financial Performance 10.4.4.3. Product Benchmarking 10.4.4.4. Strategic Initiatives 10.4.5. Boehringer Ingelheim Gmbh 10.4.5.1. Participant’s Overview 10.4.5.2. Financial Performance 10.4.5.3. Product Benchmarking 10.4.5.4. Strategic Initiatives 10.4.6. Elanco Animal Health Incorporated 10.4.6.1. Participant’s Overview 10.4.6.2. Financial Performance 10.4.6.3. Product Benchmarking 10.4.6.4. Strategic Initiatives 10.4.7. Virbac 10.4.7.1. Participant’s Overview 10.4.7.2. Financial Performance 10.4.7.3. Product Benchmarking 10.4.7.4. Strategic Initiatives 10.4.8. Phibro Animal Health Corporation 10.4.8.1. Participant’s Overview 10.4.8.2. Financial Performance 10.4.8.3. Product Benchmarking 10.4.8.4. Strategic Initiatives 10.4.9. Dechra Pharmaceuticals Plc 10.4.9.1. Participant’s Overview 10.4.9.2. Financial Performance 10.4.9.3. Product Benchmarking 10.4.9.4. Strategic Initiatives 10.4.10. Bimeda, Inc. 10.4.10.1. Participant’s Overview 10.4.10.2. Financial Performance 10.4.10.3. Product Benchmarking 10.4.10.4. Strategic Initiatives 10.4.11. Biogénesis Bagó. 10.4.11.1. Participant’s Overview 10.4.11.2. Financial Performance 10.4.11.3. Product Benchmarking 10.4.11.4. Strategic Initiatives 10.4.12. Ourofino Saúde Animal. 10.4.12.1. Participant’s Overview 10.4.12.2. Financial Performance 10.4.12.3. Product Benchmarking 10.4.12.4. Strategic Initiatives 10.4.13. FARMABASE 10.4.13.1. Participant’s Overview 10.4.13.2. Financial Performance 10.4.13.3. Product Benchmarking 10.4.13.4. Strategic Initiatives 10.4.14. Vetnil 10.4.14.1. Participant’s Overview 10.4.14.2. Financial Performance 10.4.14.3. Product Benchmarking 10.4.14.4. Strategic Initiatives 10.4.15. Alivira Saúde Animal 10.4.15.1. Participant’s Overview 10.4.15.2. Financial Performance 10.4.15.3. Product Benchmarking 10.4.15.4. Strategic Initiatives Chapter 11. Key Takeaways
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Grand View Research社のアニマルヘルス分野での最新刊レポート
本レポートと同じKEY WORD(biologics)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/12 10:26 153.40 円 161.58 円 198.54 円 |